Pharmaceuticals Market Reports

Global Systemic Lupus Erythematosus Market Size, Trends & Analysis - Forecasts to 2026 By Drug Class (Antimalarial Drugs, Non-Steroidal Anti-Inflammatory Drugs, Immunosuppressants, Corticosteroids, Disease-Modifying Anti-Rheumatic Drugs, BLyS-specific Inhibitors or Monoclonal Antibodies, Anticoagulants, Biologics, Others), By Route of Administration (Oral, Intravenous, Subcutaneous), By Region (North America, Europe, Asia Pacific, MEA, and CSA); End-User Landscape, Company Market Share Analysis & Competitor Analysis

The systemic lupus erythematosus market is estimated to be valued at USD 3.30 Billion in 2021 and is projected to reach USD 4.67 Billion by 2026 at a CAGR of 7.2%. The core drivers which contribute to the market expansion include the increasing prevalence of chronic diseases, the growing need for targeted treatment, soaring levels of inflammatory diseases, increasing therapeutic interventions, and the emergence of biologics. Read More »
July 21 : 2021

Global Hyperlipidemia Drugs Market Size, Trends & Analysis - Forecasts to 2026 By Drug Class (Statins, PCSK9 Inhibitors, Bile Acid Sequestrants, Cholesterol Absorption Inhibitors, Fibric Acid Derivatives, Combination, Others), By End-User (Hospitals, Clinics, Others), By Region (North America, Europe, Asia Pacific, MEA, and CSA); End-User Landscape, Company Market Share Analysis & Competitor Analysis

The hyperlipidemia drugs market is estimated to be valued at USD 21.84 Billion in 2021 and is projected to reach USD 24.71 Billion by 2026 at a CAGR of 2.5%. The key drivers which contribute to the market include the increased incidence of chronic disorders such as diabetes, heart diseases, and cancer, increasing unusual cholesterol levels, addiction to ready-to-eat products, and an upsurge in high-density lipoprotein (HDL) and low-density lipoprotein (LDL) levels. Read More »
July 20 : 2021

Global Rheumatoid Arthritis Therapeutics Market Size, Trends & Analysis - Forecasts to 2026 By Product (Biologics, Non-Biologics, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Synthetic Disease-Modifying Antirheumatic Drugs, Other), Sales Channel (Prescription, OTC), By Route of Administration (Oral, Parenteral), By Region (North America, Europe, Asia Pacific, MEA, and CSA); End-User Landscape, Vendor Landscape, and Company Market Share Analysis and Competitor Analysis

The global rheumatoid arthritis therapeutics market is estimated to be valued at USD 25.66 billion in 2021 and is projected to reach USD 32.44 billion by 2026 at a CAGR of 4.8%. The key drivers which contribute to the market expansion include the increasing prevalence of chronic diseases, growing joint deformities, soaring need for advanced treatment solutions, growing inflammatory diseases, increasing emergence of biologics, a growing proportion of individuals suffering from autoimmune disorders, mounting demand & desire for novel therapeutics, continually evolving medical facilities, growing geriatric population, increasing technological advancements, expanding government initiatives, rising legal governance alignment, and increasing research and development. Read More »
July 16 : 2021

Global Local Anesthesia Drugs Market Size, Trends & Analysis - Forecasts to 2026 By Product (Bupivacaine, Ropivacaine, Lidocaine, Chloroprocaine, Prilocaine, Benzocaine), By Application (Injectable, Surface Anesthetic), By Distribution Channel (Hospital Pharmacy, Pharmacy Stores, Other), By Region (North America, Europe, Asia Pacific, MEA, and CSA); End-User Landscape, Vendor Landscape, and Company Market Share Analysis and Competitor Analysis

The global local anesthesia drugs market is estimated to be valued at USD 5.60 billion in 2021 and is projected to reach USD 6.75 billion by 2026 at a CAGR of 3.8%. The core drivers which contribute to the market expansion include the increasing volume of surgeries related to chronic diseases, cardiovascular, accidents, cancer, nervous disorders and even getting relief from post-surgery. Read More »
July 15 : 2021

Global Fatty Acid Oxidation Disorder Market Size, Trends, and Analysis - Forecasts To 2026 By Drug Type (Levocarnitine, Dextrose, Riboflavin, and Others), By Route of Administration (Oral and Intravenous), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, and Online Stores), By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa); End-User Landscape, Company Market Share Analysis & Competitor Analysis

The overall population is expected to reach 8.5 billion by 2030, leading to an increase in the worldwide consumption of numerous products. Expanding need for sustainable bio-products including soaps, food emulsifiers, surface cleaners, detergents, fertilizers, cosmetics, paints, and skincare items has raised the fatty acid market requirement for industrial commercial, and consumer use. Read More »
June 9 : 2021

Global Bipolar Disorder Market Size, Trends & Analysis - Forecasts to 2026 By Mechanism of Action (Benzodiazepines, Selective serotonin reuptake inhibitor, Serotonin-norepinephrine reuptake inhibitor, Tricyclic antidepressant drugs, Monoamine oxidase inhibitors, Beta-blockers, Others) By Drug Class (Antidepressant drugs, Mood stabilizer, Anticonvulsants, Antianxiety drugs, Antipsychotic drugs) By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa); End-User Landscape, Company Market Share Analysis & Competitor Analysis

In the projected period, technological developments and the acceptance of a sedentary lifestyle are anticipated to propel the growth of the bipolar disorder treatment market. Also, expanding factors such as genetics and the environment may affect brain structure and chemistry, leading to the development of bipolar illnesses, which would enhance numerous prospects, resulting in the growth of the bipolar disorder treatment market over the projection period. Read More »
June 4 : 2021